SABBY MANAGEMENT, LLC - Q1 2022 holdings

$670 Million is the total value of SABBY MANAGEMENT, LLC's 147 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 75.0% .

 Value Shares↓ Weighting
BuySPDR S&P 500 ETF TRcall$99,993,000
+71.6%
2,214
+80.4%
14.93%
+76.2%
BuyDIGITAL WORLD ACQUISITION COput$66,516,000
+1222.4%
10,311
+954.3%
9.93%
+1258.7%
BuyISHARES RUSSELL 2000call$63,141,000
+437.6%
3,076
+482.6%
9.43%
+452.0%
BuyISHARES RUSSELL 2000put$56,244,000
+24.1%
2,740
+34.5%
8.40%
+27.5%
NewSPDR S&P 500 ETF TRput$50,934,0001,642
+100.0%
7.61%
NewDIGITAL WORLD ACQUISITION COcall$34,268,0005,312
+100.0%
5.12%
VRPX BuyVIRPAX PHARMACEUTICALS INC$18,339,000
+509.7%
1,005,156
+14.6%
2.74%
+526.5%
BuyBRIACELL THERAPEUTICS CORPput$6,610,000
+85.6%
6,519
+51.6%
0.99%
+90.5%
NewPERSHING SQUARE TONTINE HLDGcall$3,992,0002,007
+100.0%
0.60%
PMCBD BuyPHARMACYTE BIOTECH INC$2,934,000
-3.6%
1,275,468
+4.7%
0.44%
-1.1%
NBEV BuyNEWAGE INC$2,299,000
-6.8%
3,956,726
+65.2%
0.34%
-4.5%
NRXP NewNRX PHARMACEUTICALS INC$1,917,000782,473
+100.0%
0.29%
BuyKEMPHARM INCput$1,836,000
-27.6%
3,651
+27.4%
0.27%
-25.7%
NewPULMATRIX INC$1,625,000237,958
+100.0%
0.24%
CLBS BuyCALADRIUS BIOSCIENCES INC$1,483,000
+9.7%
2,371,525
+47.6%
0.22%
+12.2%
RWLK BuyREWALK ROBOTICS LIMITED$1,474,000
+16.1%
1,271,062
+23.1%
0.22%
+18.9%
AFIB BuyACUTUS MEDICAL INC$1,416,000
-44.3%
1,018,950
+36.7%
0.21%
-43.0%
VINC BuyVINCERX PHARMA INC$1,309,000
-50.4%
327,236
+26.4%
0.20%
-49.2%
KMPH BuyKEMPHARM INC$1,302,000
+648.3%
258,780
+1193.9%
0.19%
+676.0%
NewUS WELL SERVICES INCcl a$1,072,000974,275
+100.0%
0.16%
NewCORE SCIENTIFIC INCcall$1,067,0001,296
+100.0%
0.16%
AGTC NewAPPLIED GENETIC TECHNOLOGIES$1,038,000970,057
+100.0%
0.16%
BTCM NewBIT MINING LIMITEDadr$969,000347,299
+100.0%
0.14%
ANY BuySPHERE 3D CORP$909,000
+38.8%
432,840
+106.3%
0.14%
+43.2%
BuyACTINIUM PHARMACEUTICALS INCcall$868,000
+3.3%
1,699
+21.5%
0.13%
+6.6%
CBIO BuyCATALYST BIOSCIENCES INC$871,000
-16.2%
1,320,000
+16.0%
0.13%
-13.9%
ASLN BuyASLAN PHARMACEUTICALS LIMITEDads$839,000
-16.8%
932,399
+3.6%
0.12%
-15.0%
CRIS BuyCURIS INC$823,000
-23.7%
345,905
+52.7%
0.12%
-21.7%
ATHX BuyATHERSYS INC$816,000
+677.1%
291,444
+150.3%
0.12%
+713.3%
NewTANTECH HOLDINGS LTD$734,0001,541,060
+100.0%
0.11%
NewSPLASH BEVERAGE GROUP INCput$733,0002,581
+100.0%
0.11%
BuyHARBOR CUSTOM DEV INC*w$730,000
-50.4%
1,973,494
+3.3%
0.11%
-49.1%
NewIMPERIAL PETE INCput$604,0004,168
+100.0%
0.09%
NewSPI ENERGY CO LTD$550,000191,624
+100.0%
0.08%
BuyREWALK ROBOTICS LIMITEDput$493,000
+2.3%
4,254
+8.7%
0.07%
+5.7%
ATOS NewATOSSA THERAPEUTICS INC$453,000362,072
+100.0%
0.07%
BuyGUARDFORCE AI CO LTD*w$443,000
-18.1%
1,163,566
+9.7%
0.07%
-16.5%
AMPGW BuyAMPLITECH GROUP INC*w$438,000
-22.6%
455,920
+3.2%
0.06%
-20.7%
NewCONTRAFECT CORPcall$414,0001,135
+100.0%
0.06%
LEXXW BuyLEXARIA BIOSCIENCE CORP*w$383,000
-37.5%
425,883
+4.2%
0.06%
-36.0%
NewSMART FOR LIFE INC$369,000329,537
+100.0%
0.06%
BuyDIGITAL ALLY INCput$357,000
+19.8%
3,277
+17.6%
0.05%
+23.3%
SBEV NewSPLASH BEVERAGE GROUP INC$348,000122,698
+100.0%
0.05%
CHEK NewCHECK CAP LTD$340,000875,057
+100.0%
0.05%
NewCEA INDUSTRIES INC$334,000133,081
+100.0%
0.05%
BuyBIT MINING LIMITEDput$321,000
-47.8%
1,152
+15.0%
0.05%
-46.1%
BuyCBAK ENERGY TECHNOLOGY INCput$319,000
-14.7%
2,492
+3.9%
0.05%
-11.1%
BCTX NewBRIACELL THERAPEUTICS CORP$304,00029,962
+100.0%
0.04%
BuyAPPLIED GENETIC TECHNOLOGIESput$293,000
+1173.9%
2,737
+2180.8%
0.04%
+1366.7%
NewCYREN LTD$290,00057,493
+100.0%
0.04%
NewESPORTS ENTERTAINMENT GROUP*w$270,0001,000,000
+100.0%
0.04%
CBAT BuyCBAK ENERGY TECHNOLOGY INC$256,000
-2.3%
200,025
+19.2%
0.04%0.0%
BuyTRICIDA INCcall$226,000
-92.8%
4,738
+43.7%
0.03%
-92.6%
MOGO NewMOGO INC$197,00067,651
+100.0%
0.03%
BuyGLOBUS MARITIME LIMITEDput$189,000
+47.7%
819
+34.7%
0.03%
+47.4%
NewBIT BROTHER LIMITEDcl a$170,000500,000
+100.0%
0.02%
BuyPHARMACYTE BIOTECH INCput$158,000
-4.8%
687
+3.3%
0.02%0.0%
BuyCINGULATE INC*w$156,000
-56.1%
555,754
+11.2%
0.02%
-55.8%
BuyMOGO INCput$145,000
-13.2%
497
+1.6%
0.02%
-8.3%
NewMODULAR MEDICAL INC$133,00030,285
+100.0%
0.02%
BuyHEARTBEAM INC*w$133,000
-50.7%
360,458
+0.0%
0.02%
-48.7%
NewIMPERIAL PETE INC$125,00086,466
+100.0%
0.02%
NOVN BuyNOVAN INC$114,000
+42.5%
28,838
+50.7%
0.02%
+41.7%
PPBT NewPURPLE BIOTECH LTDads$105,00026,672
+100.0%
0.02%
BKYI BuyBIO-KEY INTERNATIONAL INC$105,000
+34.6%
43,652
+23.1%
0.02%
+45.5%
WIMI BuyWIMI HOLOGRAM CLOUD INCads$89,000
+107.0%
33,400
+135.1%
0.01%
+116.7%
BuyALPINE 4 HOLDINGS INCput$77,000
+175.0%
735
+403.4%
0.01%
+175.0%
BIOC BuyBIOCEPT INC$71,000
+4.4%
30,502
+63.4%
0.01%
+10.0%
BuyARCADIA BIOSCIENCES INCput$77,000
+37.5%
553
+2.6%
0.01%
+37.5%
EQOS BuyEQONEX LTD$76,000
+94.9%
33,887
+62.9%
0.01%
+83.3%
BuyTRICIDA INCput$59,000
-94.5%
1,229
+10.1%
0.01%
-94.2%
NewESPERION THERAPEUTICS INCcall$46,000100
+100.0%
0.01%
NewBAUDAX BIO INC$33,00018,900
+100.0%
0.01%
NewEQONEX LTDput$28,000125
+100.0%
0.00%
SYTA NewSIYATA MOBILE INC$13,00010,184
+100.0%
0.00%
NewAPPLIED GENETIC TECHNOLOGIEScall$15,000140
+100.0%
0.00%
NewESPORTS ENTERTAINMENT GROUPput$7,000100
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings